Gaona-López, C.; Méndez-Álvarez, D.; Gonzalez-Gonzalez, A.; Avalos-Navarro, G.; Paz-González, A.D.; Moreno-Rodríguez, A.; Nogueda-Torres, B.; Rivera, G.
In Silico Investigation of TATA-Binding Protein as a Therapeutic Target for Chagas Disease: Insights into FDA Drug Repositioning. Pharmaceuticals 2025, 18, 845.
https://doi.org/10.3390/ph18060845
AMA Style
Gaona-López C, Méndez-Álvarez D, Gonzalez-Gonzalez A, Avalos-Navarro G, Paz-González AD, Moreno-Rodríguez A, Nogueda-Torres B, Rivera G.
In Silico Investigation of TATA-Binding Protein as a Therapeutic Target for Chagas Disease: Insights into FDA Drug Repositioning. Pharmaceuticals. 2025; 18(6):845.
https://doi.org/10.3390/ph18060845
Chicago/Turabian Style
Gaona-López, Carlos, Domingo Méndez-Álvarez, Alonzo Gonzalez-Gonzalez, Guadalupe Avalos-Navarro, Alma D. Paz-González, Adriana Moreno-Rodríguez, Benjamín Nogueda-Torres, and Gildardo Rivera.
2025. "In Silico Investigation of TATA-Binding Protein as a Therapeutic Target for Chagas Disease: Insights into FDA Drug Repositioning" Pharmaceuticals 18, no. 6: 845.
https://doi.org/10.3390/ph18060845
APA Style
Gaona-López, C., Méndez-Álvarez, D., Gonzalez-Gonzalez, A., Avalos-Navarro, G., Paz-González, A. D., Moreno-Rodríguez, A., Nogueda-Torres, B., & Rivera, G.
(2025). In Silico Investigation of TATA-Binding Protein as a Therapeutic Target for Chagas Disease: Insights into FDA Drug Repositioning. Pharmaceuticals, 18(6), 845.
https://doi.org/10.3390/ph18060845
